Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular diagnostics in melanoma.

J Andrew Carlson1, Jeffery S Ross, Andrzej Slominski

  • 1Division of Dermatopathology, Albany Medical College, Albany, New York 12208, USA. carlsoa@mail.amc.edu

Journal of the American Academy of Dermatology
|April 29, 2005
PubMed
Summary

Molecular pathology advancements offer new ways to diagnose melanoma, predict its progression, and guide treatment. New molecular markers show promise for personalized melanoma care and monitoring treatment response.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pmel17 Deficiency Affects Melanogenesis and Promotes Tumor Vascularization.

International journal of molecular sciences·2026
Same author

Grape constituents for protection against photodamage to skin.

Photochemistry and photobiology·2025
Same author

Dissection of an impact of VDR and RXRA on the genomic activity of 1,25(OH)<sub>2</sub>D<sub>3</sub> in A431 squamous cell carcinoma.

Molecular and cellular endocrinology·2023
Same author

The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II-III and metastatic breast cancers.

Breast cancer research and treatment·2022
Same author

The Genomics of Colorectal Cancer in Populations with African and European Ancestry.

Cancer discovery·2022
Same author

The Challenge of Melanoma Chemoprevention.

Cancer prevention research (Philadelphia, Pa.)·2022

Area of Science:

  • Molecular pathology
  • Dermatology
  • Oncology

Background:

  • Current primary cutaneous melanoma diagnosis and prognosis rely on histologic (e.g., tumor depth, ulceration) and clinical (metastasis) factors.
  • Existing methods have limitations, as metastasis can occur in thin melanomas and sentinel lymph node biopsy doesn't identify all at-risk patients.
  • Limited therapeutic options currently exist for melanoma, with no regimen proven to prolong survival.

Purpose of the Study:

  • To discuss molecular diagnostics that can potentially benefit individual melanoma patients.
  • To explore novel markers aiding in melanoma identification, prognostication, and minimal residual disease detection.
  • To review the role of molecular markers in selecting effective therapies and monitoring treatment response.

Main Methods:

Related Experiment Videos

  • Review of emerging molecular diagnostic technologies and their application in melanoma.
  • Analysis of existing and novel biomarkers correlating with melanoma progression and treatment response.
  • Discussion of investigational therapies and their potential molecular targets.

Main Results:

  • New molecular markers show correlation with melanoma progression, potentially improving identification and prognostication.
  • These markers may aid in detecting minimal residual disease and early recurrence.
  • Emerging data suggests molecular markers are crucial for identifying patients likely to respond to specific therapies.

Conclusions:

  • Molecular diagnostics represent a rapidly evolving field with significant potential to enhance melanoma patient care.
  • Personalized medicine approaches using molecular markers can improve diagnosis, prognosis, and therapeutic selection for melanoma.
  • Further research into molecular diagnostics is essential for advancing melanoma treatment and patient outcomes.